FAK Inhibition Remodels the Metastatic ECM and Restores CD8+ T Cell Trafficking and Immunosurveillance
Nicole D. Barth, Bo Peng, Michael Papanicolaou, Fatemeh Ahmadi Moughari, Camille L. Duran, Christopher S. McGinnis, John C. Dawson, Emily R. Webb, Morwenna Muir, Fraser Laing, Yookyung Jung, Xue‐Yan He, Ansuman T. Satpathy, Mikala Egeblad, Syed Aleem Haider, , Valerie G. Brunton
This paper shows that FAK inhibition remodels the metastatic ECM, enhancing CD8+ T cell infiltration and immunosurveillance in breast cancer.
bioRxiv · Jan 23, 2026 · PreprintCancer Biology